_compressed.jpg)
MVE Brooks BioStore III Cryo 190C Storage System Automated Inventory Mgmt
MVE/Brooks
Details
-
CategoryCold Storage
-
Dimension68.0in x 62.0in x 76.0in
-
SerialCAB2121270043
-
Shipping TypeFreight
-
ManufacturingDoes Not Apply
-
Voltage / Hertz120V / 60Hz US
Description
The MVE/Brooks BioStore III Cryo LN2-Based Automated Storage System is a reliable choice for researchers and biobank managers. Designed to provide maximum protection for cellular products and biosamples, it operates at a cryogenic temperature of -190°C. The high-efficiency LN2 stainless steel freezer integrates comprehensive inventory management and control, making it an affordable automation solution that competes well with manual LN2 freezers. This unit holds up to 252 cryoboxes, monitors sample inventories, provides audit-trail reports, and ensures cold chain management even during power or LN2 interruption, with over 20 days of temperature stability. Although it powers on and passes basic tests, the equipment's full functionality can't be tested; however, there are no indications of defects. Note: power cord, software, or computer is not included.
Technician comment
Featured image for display purposes only. Does not include pc or software. See photos for details.
Key Features
- Automated sample storage at -190°C
- Holds up to 252 cryoboxes
- Comprehensive inventory management
- Cold chain protection for 20+ days
- Improved security with user access logging
Specifications
- Temperature: Cryogenic -190°C
- Capacity: Up to 252 cryoboxes
- Security: Admin-controlled access
- Inventory: Real-time viewing and tracking
- Voltage: 120V, Frequency: 60Hz
Weight
Imperial: 2160.0 Pounds
Metric: 979.76 Kilograms
Shipping Dimensions
Imperial: 81.6 lb x 74.4 lb x 91.2 lb
Metric: 207.26 cm x 188.98 cm x 231.65 cm
Harmonized Code
8419600000
Harmonized Code Details
8419600000 - Machinery for liquefying air or gas, not classified elsewhere. Selected based on the system's function in cryogenic storage and liquefaction processes.
Comments 0
There are currently no public comments.